CONGRESS|#EHA2021|@szusmani @LevineCancer
presented poster for results from CARTITUDE-1 study where a single infusion of cita-cel yielded deep & durable responses in heavily pretreated MM pts with manageable safety profile at RP2D #mmsm #myeloma https://t.co/Ku0LPnsBHL pic.twitter.com/lBYbxUR9uX
— Multiple Myeloma Hub (@MM_Hub) June 16, 2021